发明名称 |
RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO |
摘要 |
A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus. |
申请公布号 |
US2015335700(A1) |
申请公布日期 |
2015.11.26 |
申请号 |
US201514814151 |
申请日期 |
2015.07.30 |
申请人 |
Previvo Genetics, LLC |
发明人 |
Carson Sandra Ann;Buster John E.;Cesario Moses;Woodard Steven Paul |
分类号 |
A61K38/08;A61K31/58;A61K31/575;A61K31/573;A61K31/57;A61K31/215 |
主分类号 |
A61K38/08 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition suitable for administration to a human female patient after superovulation comprising a GnRH antagonist in a pharmaceutically acceptable carrier at a dosage amount of about 0.5 to 400 mg, sufficient to cause corpus luteum apoptosis leading to desynchronization of the endometrium prior to, during, or following recovery of blastocysts from the uterus of the patient. |
地址 |
Piedmont CA US |